Icotrokinra

Overview

Icotrokinra is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL6068124).

API suppliers (1)

Suppliers of Icotrokinra backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTDChina1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Icotrokinra expires 19 Nov 2041 and exclusivity 17 Mar 2031. Generic API sourcing typically opens up once these lapse.